Tempest Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 05/15/2026 | 233.89 K | $383.58 K | 100.00% | 5.64% | |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 86.99 K | $142.67 K | 97.20% | 2.10% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 68.91 K | $113.01 K | 100.00% | 1.66% |
| BLACKROCK, INC. | 05/13/2026 | 39.07 K | $64.07 K | 0.00% | 0.94% |
| FMR LLC | 05/15/2026 | 33.23 K | $54.49 K | 0.00% | 0.80% |
| SABBY MANAGEMENT, LLC | 05/15/2026 | 17.86 K | $29.28 K | -90.00% | 0.43% |
| NORTHERN TRUST CORP | 05/14/2026 | 14.05 K | $23.05 K | 0.00% | 0.34% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 11.44 K | $18.77 K | 0.00% | 0.28% |
| UBS GROUP AG | 05/05/2026 | 4.53 K | $7.43 K | -74.16% | 0.11% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 2.79 K | $4.58 K | 110.57% | 0.07% |
| MORGAN STANLEY | 05/15/2026 | 2.06 K | $3.38 K | 0.00% | 0.05% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 1.53 K | $2.50 K | -5.21% | 0.04% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/14/2026 | 292 | $479 | 0.00% | 0.01% |
| JONES FINANCIAL COMPANIES LLLP | 05/15/2026 | 239 | $413 | 0.00% | 0.01% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 168 | $276 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 56 | $92 | 0.00% | 0.00% |
| PARALLEL ADVISORS, LLC | 06/03/2026 | 18 | $30 | 0.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 8 | $13 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 5 | $8 | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 3 | $5 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
Tempest Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 26 institutional investors and hedge funds held shares of Tempest Therapeutics Inc. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 86,990
VANGUARD FIDUCIARY TRUST CO: 68,908
BlackRock, Inc.: 39,068
FMR LLC: 33,225
SABBY MANAGEMENT, LLC: 17,856
NORTHERN TRUST CORP: 14,053
12.46% of Tempest Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 997.12 K shares in the last 24 months. This purchase volume represents approximately $2.38 M in transactions.